<div id="gangagen-mission" class="gg-japanese-laurel">
  <div class="centerize ctz-lg px-3 py-5 text-center">
    <h2 class="fw-700 abx-white-text anim-hidden fade-in">Our mission is to discover, design and develop highly specific and safe Protein Antiobiotics for treating bacterial infections.</h2>
  </div>
</div>

<div id="gangagen-overview">

  	<div class="abx-white">
        <div class="centerize ctz-lg px-3 py-5">
           <div class="row">
              <div class="col-12 col-md-6 py-3">
                  <div class="content-group mb-4 anim-hidden fade-in-left">
                    <h2 class="gg-japanese-laurel-text fw-700">GangaGen Overview</h2>
                    <p style="line-height:2;">GangaGen Biotechnologies Private Limited (GBPL) is a biologics company specialized in discovering, designing and developing novel therapies for treating serious bacterial infections. GangaGen advanced it’s candidate compound into human clinical trials for the clearance of Methicillin Resistant Staphylococcus aureus from human nares in 2015.</p>
                  </div>
              </div>
              <div class="col-12 col-md-6 py-3 text-center">
                  <div class="content-group mb-4 anim-hidden fade-in-right">
                    <img src="https://via.placeholder.com/400x300.png?text=GangaGen+Placeholder+Image" alt="gangagen-image" />
                  </div>
              </div>
           </div>
        </div>
    </div>
  
    <div class="gg-light">
        <div class="centerize ctz-lg px-3 py-5">
           <div class="row">
                <div class="col-12 col-md-6 py-3 text-center">
                    <div class="content-group mb-4 anim-hidden fade-in-left">
                      <img src="https://via.placeholder.com/400x300.png?text=GangaGen+Placeholder+Image" alt="gangagen-image" />
                    </div>
                </div>
             	<div class="col-12 col-md-6 py-3">
                    <div class="content-group mb-4 anim-hidden fade-in-right">
                      <h2 class="gg-japanese-laurel-text fw-700">GangaGen's Beginnings</h2>
                      <p style="line-height:2;">GBPL was founded and registered in India in 2000 by Prof J. Ramachandran and became a subsidiary of GangaGen Incorporation, a Delaware company in the US in 2001. The assets of GangaGen Inc. were transferred to Bactoclear Holdings in 2019.</p>
                    </div>
                </div>
            </div>
        </div>
  	</div>
  
    <div class="abx-white">
        <div class="centerize ctz-lg px-3 py-5">
           <div class="row">
                <div class="col-12 col-md-6 py-3">
                    <div class="content-group mb-4 anim-hidden fade-in-left">
                      <h2 class="gg-japanese-laurel-text fw-700">GangaGen Ownership</h2>
                      <p style="line-height:2;">Presently, GBPL is a fully owned subsidiary of <a class="gg-japanese-laurel-text" href="https://bactoclear.com" target="_blank">Bactoclear Holdings Pte. Limited, Singapore</a>. The board of Bactoclear Holdings is made up of investors from different parts of the world, committed to make a difference in tackling antimicrobial resistance.</p>
                    </div>
                </div>
             	<div class="col-12 col-md-6 py-3 text-center">
                    <div class="content-group mb-4 anim-hidden fade-in-right">
                      <img src="https://via.placeholder.com/400x300.png?text=GangaGen+Placeholder+Image" alt="gangagen-image" />
                    </div>
                </div>
            </div>
        </div>
  	</div>
  
  	<div class="gg-japanese-laurel abx-white-text px-3 py-5 text-center">
      <h2>GangaGen's Research Focus</h2>
      <p>GangaGen’s expertise towards designing novel Protein Antibiotics is based on the proprietary technology platforms</p>
    </div>
  
    <div class="gg-light">
        <div class="centerize ctz-lg px-3 py-5">
           <div class="row">
                
            </div>
        </div>
   	</div>
  
</div>